- Home
- BBGI vs AYTU Comparison
BBGI vs AYTU Comparison
Compare BBGI & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- AYTU
- Stock Information
- Founded
- BBGI 1961
- AYTU N/A
- Country
- BBGI United States
- AYTU United States
- Employees
- BBGI N/A
- AYTU N/A
- Industry
- BBGI Broadcasting
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- AYTU Health Care
- Exchange
- BBGI Nasdaq
- AYTU Nasdaq
- Market Cap
- BBGI 8.1M
- AYTU 9.6M
- IPO Year
- BBGI 2000
- AYTU N/A
- Fundamental
- Price
- BBGI $3.90
- AYTU $2.10
- Analyst Decision
- BBGI
- AYTU
- Analyst Count
- BBGI 0
- AYTU 0
- Target Price
- BBGI N/A
- AYTU N/A
- AVG Volume (30 Days)
- BBGI 76.3K
- AYTU 624.8K
- Earning Date
- BBGI 08-11-2025
- AYTU 05-14-2025
- Dividend Yield
- BBGI N/A
- AYTU N/A
- EPS Growth
- BBGI N/A
- AYTU N/A
- EPS
- BBGI N/A
- AYTU N/A
- Revenue
- BBGI $234,823,730.00
- AYTU $81,659,000.00
- Revenue This Year
- BBGI $5.02
- AYTU N/A
- Revenue Next Year
- BBGI N/A
- AYTU $8.68
- P/E Ratio
- BBGI N/A
- AYTU $11.39
- Revenue Growth
- BBGI N/A
- AYTU 0.41
- 52 Week Low
- BBGI $3.67
- AYTU $0.95
- 52 Week High
- BBGI $14.95
- AYTU $2.96
- Technical
- Relative Strength Index (RSI)
- BBGI 33.07
- AYTU 60.77
- Support Level
- BBGI $3.67
- AYTU $1.97
- Resistance Level
- BBGI $5.26
- AYTU $2.17
- Average True Range (ATR)
- BBGI 0.29
- AYTU 0.14
- MACD
- BBGI -0.04
- AYTU 0.00
- Stochastic Oscillator
- BBGI 14.47
- AYTU 58.33
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.